IL10 and myeloid sarcoma: Upon reconstitution post treatment, B cell populations are predominantly naïve (CD27−), exhibiting increased IL-10 production and reduced proinflammatory cytokine production (Barr et al., 2012; Li et al., 2015b), indicating the pathogenic role of memory B cells in MS.